Key facts
- It has raised $1.8M; the latest was Early Stage VC in May 2025.
- Notable investors include Northern Light Venture Capital, Leading Capital Company, Guangzhou Jinkong Fund, Sicon Group, Wuhan East Lake High Technology Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Migesi Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Migesi Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Migesi Medical
Developer and provider of innovative devices designed for minimally invasive ophthalmology. The company's innovation is based on active cationic polymer biomaterial technology, providing surgeons and doctors with innovative ophthalmology devices.
- Sector
- Healthcare
- HQ
- Chongqing, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Migesi Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Migesi Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Migesi Medical in its N-PORT filings yet. We sweep new filings monthly.